Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Woltering

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Arthritis Care & Research|December 17, 2013
Effect of certolizumab pegol on multiple facets of psoriatic arthritis as reported by patients: 24-week patient-reported outcome results of a phase III, multicenter studyD Gladman, R Fleischmann, G Coteur, et al.
Angiology|March 24, 1999
Randomized reliability study evaluating constant-load and graded-exercise treadmill test for intermittent claudicationM Cachovan, W Rogatti, F Woltering, et al.
European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery|November 21, 1997
Treadmill testing for evaluation of claudication: comparison of constant-load and graded-exercise testsM Cachovan, W Rogatti, A Creutzig, et al.
Arthritis Care & Research|April 3, 2015
Impact of Certolizumab Pegol on Patient-Reported Outcomes in Patients With Axial SpondyloarthritisJ Sieper, A Kivitz, A van Tubergen, et al.
American Journal of Therapeutics|May 10, 2001
Prevention of contrast media-induced renal dysfunction with prostaglandin E1: a randomized, double-blind, placebo-controlled studyM H Sketch, A Whelton, E Schollmayer, et al.
Annals of the Rheumatic Diseases|August 15, 2013
Effect of different imputation approaches on the evaluation of radiographic progression in patients with psoriatic arthritis: results of the RAPID-PsA 24-week phase III double-blind randomised placebo-controlled study of certolizumab pegolD van der Heijde, R Fleischmann, J Wollenhaupt, et al.
Annals of the Rheumatic Diseases|August 15, 2013
Effect of certolizumab pegol on signs and symptoms in patients with psoriatic arthritis: 24-week results of a Phase 3 double-blind randomised placebo-controlled study (RAPID-PsA)P J Mease, R Fleischmann, A A Deodhar, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Arthritis Care & Research|December 17, 2013
Effect of certolizumab pegol on multiple facets of psoriatic arthritis as reported by patients: 24-week patient-reported outcome results of a phase III, multicenter studyD Gladman, R Fleischmann, G Coteur, et al.
Angiology|March 24, 1999
Randomized reliability study evaluating constant-load and graded-exercise treadmill test for intermittent claudicationM Cachovan, W Rogatti, F Woltering, et al.
European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery|November 21, 1997
Treadmill testing for evaluation of claudication: comparison of constant-load and graded-exercise testsM Cachovan, W Rogatti, A Creutzig, et al.
Arthritis Care & Research|April 3, 2015
Impact of Certolizumab Pegol on Patient-Reported Outcomes in Patients With Axial SpondyloarthritisJ Sieper, A Kivitz, A van Tubergen, et al.
American Journal of Therapeutics|May 10, 2001
Prevention of contrast media-induced renal dysfunction with prostaglandin E1: a randomized, double-blind, placebo-controlled studyM H Sketch, A Whelton, E Schollmayer, et al.
Annals of the Rheumatic Diseases|August 15, 2013
Effect of different imputation approaches on the evaluation of radiographic progression in patients with psoriatic arthritis: results of the RAPID-PsA 24-week phase III double-blind randomised placebo-controlled study of certolizumab pegolD van der Heijde, R Fleischmann, J Wollenhaupt, et al.
Annals of the Rheumatic Diseases|August 15, 2013
Effect of certolizumab pegol on signs and symptoms in patients with psoriatic arthritis: 24-week results of a Phase 3 double-blind randomised placebo-controlled study (RAPID-PsA)P J Mease, R Fleischmann, A A Deodhar, et al.
Pageof 1